Trusted by:
In the battle against breast cancer, medicine may be shooting at the wrong enemy. Much like using a weed-whacker to remove the top of lawn weeds, leaving the root behind, conventional treatments that target mature, late-acting cancer cells may miss early cells that can give rise to cancer recurrences.
A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers have found.
Study will help physicians calculate risk of post-surgical venous thromboembolisms. New research from the UC Davis Comprehensive Cancer Center may help clinicians determine which patients are at highest risk for post-surgical blood clots in the legs or lungs.
A team of UC Davis scientists has found that a product resulting from a metabolized omega-3 fatty acid helps combat cancer by cutting off the supply of oxygen and nutrients that fuel tumor growth and spread of the disease.
The most recent in a series of studies from a team at the UC Davis Comprehensive Cancer Center has shown that a single molecule is at the heart of one of the most basic survival tactics of prostate cancer cells.
Study is the first randomized trial to assess the efficacy of home-based health education for the Hmong.
The guideline, released jointly by the American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA), for the first time provides evidence- and consensus-based recommendations about the benefits and risks of additional cancer treatment after prostate-removal surgery.
Orthopedic oncologists and surgical oncologists, who have been trained in the complex procedures required to remove sarcomas located deep in the muscles and other soft tissues of the limbs, conducted only 52 percent of these operations at 85 academic medical centers during a three year period, according to an analysis of national data by UC Davis researchers that is published online today in the Journal of Surgical Oncology.
Researchers identify key mechanism behind aggressive prostate cancer that spurs tumor growth and metastasis and makes cancers resistant to treatment.
When public health budgets are constrained, mammography screening should begin later and occur less frequently, a cost-effectiveness analysis for California鈥檚 Every Woman Counts (EWC) program concludes.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right